Log in

Relevant bibliographies by topics / Antilipidemic agent

Contents

Journal articles
Dissertations / Theses
Books
Book chapters

Academic literature on the topic 'Antilipidemic agent'

Author: Grafiati

Published: 5 June 2025

Last updated: 2 August 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Antilipidemic agent.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Antilipidemic agent"

1

Vishweshwaran, S., G. Sairam, M. Shakilarani, S. Stalin, S. Swaminathan, and K. Uma Maheswari. "Evaluation of Chrysin as an Effective Antilipidemic Agent." Asian Journal of Chemistry 26, no. 9 (2014): 2617–20. http://dx.doi.org/10.14233/ajchem.2014.15759.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Abbasi, Hana, and Hifzul Kabir. "Unani Perspective and New Researches of Sa’ad ku’fi (Cyperus rotundus): A Review." Journal of Drug Delivery and Therapeutics 8, no. 6 (2018): 378–81. http://dx.doi.org/10.22270/jddt.v8i6.2059.

Full text

Abstract:

Cyperus rotundus L. (cyperaceae) is an important medicinal plant which is used in traditional medicine particularly in Unani system of medicine. It is commonly known as motha which is a lawn grass and grows easily in tropical, subtropical and temperate regions. Major Chemical constituents enclosed with this herb are flavonoids, tannins, glycosides, furochromones, monoterpenes, sesquiterpenes, sitosterol, alkaloids, saponins, terpenoids, essential oils, starch, carbohydrates, protein, separated amino acids and many other secondary metabolites. Different parts of cyperus rotundus have been repor

APA, Harvard, Vancouver, ISO, and other styles

3

Komura, T., K. Takahara, M. Sugano, et al. "Effect of LDL-apheresis on the pharmacokinetics of the lipophilic antilipidemic agent probucol." European Journal of Drug Metabolism and Pharmacokinetics 22, no. 3 (1997): 201–6. http://dx.doi.org/10.1007/bf03189807.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Thangabalan, Boovizhikannan, Nagarajan Pavithra, Palani Pavitra, Rajendran Rama, seemakurthi Jahnavika, and Nayar Ahmed Zeba. "Reported Estimation techniques for Quantification of Simvastin :- A Review." World Journal of Biology Pharmacy and Health Sciences 12, no. 2 (2022): 079–86. https://doi.org/10.5281/zenodo.7604659.

Full text

Abstract:

Simvastatin is used along with a proper diet to help lower bad cholesterol and fats and raise good cholesterol in the blood. It belongs to a group of drugs known as statins. It works by reducing the amount of cholesterol made by the liver. Lowering bad cholesterol and triglycerides and raising good cholesterol decreases the risk of heart disease and helps prevent strokes and heart attacks. There are various analytical methods for estimation of the drug. This paper list outs the various analytical methods for the drug.

APA, Harvard, Vancouver, ISO, and other styles

5

Bano, Shayara, and Jitender K. Malik. "Chlorogenic Acid a Potent Anti-inflammatory Agent: In-Silico Molecular Docking approach." Middle East Research Journal of Pharmaceutical Sciences 2, no. 1 (2021): 10–20. http://dx.doi.org/10.36348/merjps.2022.v02i01.002.

Full text

Abstract:

Abstract: Chlorogenic acid (5-O-caffeoylquinic acid) is a phenolic compound of the hydroxycinnamic acid family. This polyphenol has many health-enhancing properties, most of which are relevant for the treatment of metabolic syndrome, including antioxidant, anti-inflammatory, antilipidemic, antidiabetic, and antihypertensive effects. In addition, chlorogenic acid has antioxidant properties, especially against lipid oxidation. Protective properties against degradation and prebiotic activity of other bioactive compounds present in foods. In addition, chlorogenic acid has antioxidant properties, e

APA, Harvard, Vancouver, ISO, and other styles

6

Mikhailova, A. A., M. V. Sharypova, A. V. Simanenkova, et al. "Fibroblast growth factor 21: a novel link in the development and treatment of metabolic disorders." "Arterial’naya Gipertenziya" ("Arterial Hypertension") 30, no. 5 (2025): 441–50. https://doi.org/10.18705/1607-419x-2024-2455.

Full text

Abstract:

In recent years, fibroblast growth factor 21 (FGF21) has garnered increasing attention as a metabolic regulator. It plays a role in the development of tissue insulin sensitivity, exerts beneficial effects on carbohydrate and lipid metabolism, and exhibits antihyperglycemic and antilipidemic properties. Elevated FGF21 levels have been observed in patients with type 2 diabetes, obesity, non-alcoholic fatty liver disease, and a range of other conditions. This may indicate either resistance to FGF21 or a compensatory response to metabolic stress. Evidence suggests that FGF21 can be considered both

APA, Harvard, Vancouver, ISO, and other styles

7

Yu, Seungmin, Hee Min Lee, Jangho Lee, Jin-Taek Hwang, Hyo-Kyoung Choi та Yu Geon Lee. "Pennogenin 3-O-β-Chacotrioside Attenuates Hypertrophied Lipid Accumulation by Enhancing Mitochondrial Oxidative Capacity". International Journal of Molecular Sciences 25, № 5 (2024): 2970. http://dx.doi.org/10.3390/ijms25052970.

Full text

Abstract:

Excessive lipid accumulation in adipocytes is a primary contributor to the development of metabolic disorders, including obesity. The consumption of bioactive compounds derived from natural sources has been recognized as being safe and effective in preventing and alleviating obesity. Therefore, we aimed to explore the antilipidemic effects of pennogenin 3-O-β-chacotrioside (P3C), a steroid glycoside, on hypertrophied 3T3-L1 adipocytes. Oil Red O and Nile red staining demonstrated a P3C-induced reduction in lipid droplet accumulation. Additionally, the increased expression of adipogenic and lip

APA, Harvard, Vancouver, ISO, and other styles

8

Madaki, Fatima, Adamu Kabiru, Ogunrombi Clinton, Sakariyau Waheed, and Yunusa Ibrahim. "Evaluating the influence of Trypanosomiasis on murine model using Corchorus olitorius leaf extract as a trypanocidal agent." Bulletin of Natural Sciences Research, no. 00 (2024): 14. http://dx.doi.org/10.5937/bnsr14-51999.

Full text

Abstract:

Trypanosomiasis, a parasitic disease caused by trypanosomes, which are flagellate protozoa transmitted through the bite of the tsetse fly, manifests with symptoms including substantial weight loss, anemia, fever, edema, adenitis, dermatitis, and nervous disorders. This research investigated the impact of trypanosomiasis on a murine model while utilizing Corchorus olitorius leaf extract as a potential trypanocidal agent. An acute toxicity analysis was conducted following Lorke's method, and the antitrypanosomal efficacy was assessed in rats at doses of 100, 200, and 400 mg/kg over three weeks,

APA, Harvard, Vancouver, ISO, and other styles

9

Uma P, Venkatachalam V V, Mani Chandrika P, and Sorabh Kumar Agrawal. "Antidiabetic and Antilipidemic activity of Poly herbal formulation (PHF) in STZ-NA induced diabetes in rats." International Journal of Research in Pharmaceutical Sciences 12, no. 3 (2021): 2239–47. http://dx.doi.org/10.26452/ijrps.v12i3.4844.

Full text

Abstract:

The effects of polyherbal formulations were studied in the streptozotocin-nicotinamide (STZ-NA) induced diabetes rat model. The present study was undertaken to assess the effects of polyherbal formulations on the blood sugar level (BSL) as well as blood lipid level(BLL) of STZ-NA diabetic rats. The leaves of Moringa oleifera and roots of Raphanus raphanistrum were used for the study due to the presence of various phytoconstituents such as alkaloids, saponins, tannins, steroids, phenolic acids, flavonoids. Three polyherbal formulations were prepared from different portions of leaves of Moringa

APA, Harvard, Vancouver, ISO, and other styles

10

Uma P, Venkatachalam V V, Mani Chandrika P, and Sorabh Kumar Agrawal. "Antidiabetic and Antilipidemic activity of Poly herbal formulation (PHF) in STZ-NA induced diabetes in rats." International Journal of Research in Pharmaceutical Sciences 11, no. 4 (2020): 8092–100. http://dx.doi.org/10.26452/ijrps.v11i4.4844.

Full text

Abstract:

The effects of polyherbal formulations were studied in the streptozotocin-nicotinamide (STZ-NA) induced diabetes rat model. The present study was undertaken to assess the effects of polyherbal formulations on the blood sugar level (BSL) as well as blood lipid level(BLL) of STZ-NA diabetic rats. The leaves of Moringa oleifera and roots of Raphanus raphanistrum were used for the study due to the presence of various phytoconstituents such as alkaloids, saponins, tannins, steroids, phenolic acids, flavonoids. Three polyherbal formulations were prepared from different portions of leaves of Moringa

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "Antilipidemic agent"

1

Kim, Sung Kwang. "Benzopyranone and diastereomeric hexahydrobenzopyranone aci-reductones : antiaggregatory and antilipidemic agents /." The Ohio State University, 1986. http://rave.ohiolink.edu/etdc/view?acc_num=osu1487267024996415.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Antilipidemic agent"

1

T, Witiak Donald, Newman H. A. I, and Feller D. R, eds. Antilipidemic drugs: Medicinal, chemical and biochemical aspects. Elsevier, 1991.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Antilipidemic drugs. Elsevier, 1991.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Witiak, D. T., and H. A. I. Newman. Antilipidemic Drugs: Medicinal, Chemical and Biochemical Aspects (Pharmacochemistry Library, Vol 17). Elsevier Science Ltd, 1991.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Antilipidemic agent"

1

Tonningen, Margreet Rost van. "Gastrointestinal and antilipidemic agents and spasmolytics." In Drugs During Pregnancy and Lactation. Elsevier, 2007. http://dx.doi.org/10.1016/b978-044452072-2/50009-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

van Tonningen, Margreet Rost. "Gastrointestinal and antilipidemic agents and spasmolytics." In Drugs During Pregnancy and Lactation. Elsevier, 2007. http://dx.doi.org/10.1016/b978-0-444-52072-2.50009-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Chakraborty, Jayanta, and Semanti Chakraborty. "Safety Concerns of Currently Used Antilipidemic Agents: A Literature Review." In CSI: Cardiology Update 2015 (2 Volumes). Jaypee Brothers Medical Publishers (P) Ltd., 2016. http://dx.doi.org/10.5005/jp/books/12785_12.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!